» Articles » PMID: 20460428

Transient Inhibition of Transforming Growth Factor-beta1 in Human Diabetic CD34+ Cells Enhances Vascular Reparative Functions

Overview
Journal Diabetes
Specialty Endocrinology
Date 2010 May 13
PMID 20460428
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Peripheral blood CD34(+) cells from diabetic patients demonstrate reduced vascular reparative function due to decreased proliferation and diminished migratory prowess, largely resulting from decreased nitric oxide (NO) bioavailability. The level of TGF-beta, a key factor that modulates stem cell quiescence, is increased in the serum of type 2 diabetic patients. We asked whether transient TGF-beta1 inhibition in CD34(+) cells would improve their reparative ability.

Research Design And Methods: To inhibit TGF-beta1 protein expression, CD34(+) cells were treated ex vivo with antisense phosphorodiamidate morpholino oligomers (TGF-beta1-PMOs) and analyzed for cell surface CXCR4 expression, cell survival in the absence of added growth factors, SDF-1-induced migration, NO release, and in vivo retinal vascular reparative ability.

Results: TGF-beta1-PMO treatment of diabetic CD34(+) cells resulted in increased expression of CXCR4, enhanced survival in the absence of growth factors, and increased migration and NO release as compared with cells treated with control PMO. Using a retinal ischemia reperfusion injury model in mice, we observed that recruitment of diabetic CD34(+) cells to injured acellular retinal capillaries was greater after TGF-beta1-PMO treatment compared with control PMO-treated cells.

Conclusions: Transient inhibition of TGF-beta1 may represent a promising therapeutic strategy for restoring the reparative capacity of dysfunctional diabetic CD34(+) cells.

Citing Articles

Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review.

Danila A, Ghenciu L, Stoicescu E, Bolintineanu S, Iacob R, Sandesc M Biomedicines. 2024; 12(4).

PMID: 38672103 PMC: 11047946. DOI: 10.3390/biomedicines12040747.


The role of telomerase reverse transcriptase in the mitochondrial protective functions of Angiotensin-(1-7) in diabetic CD34 cells.

Jahan J, Joshi S, Oca I, Toelle A, Lopez-Yang C, Chacon C Biochem Pharmacol. 2024; 222:116109.

PMID: 38458330 PMC: 11007670. DOI: 10.1016/j.bcp.2024.116109.


Stem cells and diabetic retinopathy: From models to treatment.

Saha B, Roy A, Beltramo E, Sahoo O Mol Biol Rep. 2023; 50(5):4517-4526.

PMID: 36842153 DOI: 10.1007/s11033-023-08337-0.


Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy.

Liang Z, Wang Y, Li J, Yang W, Tu Y, Zhang Y Int J Ophthalmol. 2022; 15(10):1577-1585.

PMID: 36262844 PMC: 9522570. DOI: 10.18240/ijo.2022.10.03.


Transforming growth factor-β1/Thrombospondin-1/CD47 axis mediates dysfunction in CD34 cells derived from diabetic older adults.

Jahan J, Monte de Oca I, Meissner B, Joshi S, Maghrabi A, Quiroz-Olvera J Eur J Pharmacol. 2022; 920:174842.

PMID: 35217004 PMC: 8967481. DOI: 10.1016/j.ejphar.2022.174842.


References
1.
Fadini G, Miorin M, Facco M, Bonamico S, Baesso I, Grego F . Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005; 45(9):1449-57. DOI: 10.1016/j.jacc.2004.11.067. View

2.
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

3.
Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M . Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells. 2009; 27(11):2857-64. DOI: 10.1002/stem.207. View

4.
Ploemacher R, van Soest P, Boudewijn A . Autocrine transforming growth factor beta 1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor. Stem Cells. 1993; 11(4):336-47. DOI: 10.1002/stem.5530110412. View

5.
Morita N, Yamamoto M, Tanizawa T . Correlation of c-kit expression and cell cycle regulation by transforming growth factor-beta in CD34+ CD38- human bone marrow cells. Eur J Haematol. 2003; 71(5):351-8. DOI: 10.1034/j.1600-0609.2003.00152.x. View